tiprankstipranks
Moderna (MRNA)
NASDAQ:MRNA

Moderna Stock Price & Analysis

13,355 Followers

MRNA Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$115.61 - $390.60
Previous Close$122.15
Volume4.76M
Average Volume (3M)4.87M
Market CapN/A
Enterprise ValueN/A
Total Cash (Recent Filing)$3.28B
Total Debt (Recent Filing)$211.73M
P/E Ratio3.7
Beta2.23
Next EarningsNov 03, 2022
Next Dividend Ex-DateN/A
Dividend YieldN/A
EPS (TTM)32.80
Shares Outstanding391,199,544
R-Squared0.10
Standard Deviation0.29
10 Day Avg. Volume5,506,706
30 Day Avg. Volume4,868,624
P/B Ratio2.66
P/S Ratio2.14
P/CF Ratio5.40
P/FCF Ratio5.20
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/EbitdaN/A
Price Target Upside81.78% Upside
Rating ConsensusModerate Buy
Alpha0.06
Number of Analyst Covering10


Financials

Yearly

P/E Ratio Range

The price to earnings ratio. This is used by investors to assess a stock’s market price relative to its earnings.

---

Risk Analysis

Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products

Product Monthly Users

Sorry, No Data Available
There is no website visitor data available for this stock.

---

MRNA FAQ

What was Moderna’s price range in the past 12 months?
Moderna lowest stock price was $115.61 and its highest was $390.60 in the past 12 months.
    What is Moderna’s market cap?
    Currently, no data Available
    When is Moderna’s upcoming earnings report date?
    Moderna’s upcoming earnings report date is Nov 03, 2022 which is in 34 days.
      How were Moderna’s earnings last quarter?
      Moderna released its earnings results on Aug 03, 2022. The company reported $5.24 earnings per share for the quarter, beating the consensus estimate of $4.583 by $0.657.
        Is Moderna overvalued?
        According to Wall Street analysts Moderna’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Moderna pay dividends?
          Moderna does not currently pay dividends.
          What is Moderna’s EPS estimate?
          Moderna’s EPS estimate is $4.81.
            How many shares outstanding does Moderna have?
            Moderna has 391,199,550 shares outstanding.
              What happened to Moderna’s price movement after its last earnings report?
              Moderna reported an EPS of $5.24 in its last earnings report, beating expectations of $4.583. Following the earnings report the stock price went up 15.969%.
                Which hedge fund is a major shareholder of Moderna?
                Among the largest hedge funds holding Moderna’s share is Flagship Pioneering Inc.. It holds Moderna’s shares valued at 2B.

                  ---

                  Moderna Stock Analysis

                  Smart ScoreUnderperform
                  1
                  2
                  3
                  4
                  5
                  6
                  7
                  8
                  9
                  10
                  3
                  The Moderna stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                  Learn more about TipRanks Smart Score

                  Company Description

                  Moderna

                  Incorporated in 2010, Massachusetts-based Moderna, Inc. is a clinical stage biotechnology company which develops therapeutics and vaccines based on messenger ribonucleic acid (mRNA) for the treatment of infectious diseases, immuno-oncology, rare diseases, and cardiovascular diseases. Its product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, and systemic intracellular therapeutics.

                  ---
                  Similar Stocks
                  Company
                  Price & Change
                  Follow
                  AbbVie
                  Amgen
                  Gilead Sciences
                  Vertex Pharmaceuticals
                  Regeneron

                  Popular Stocks

                  ---
                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis